Stay updated on Tisotumab Vedotin Safety in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Tisotumab Vedotin Safety in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tisotumab Vedotin Safety in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is shown on the page, replacing the previous v3.4.2. No other visible changes to the study details or layout are apparent.
    Difference
    0.0%
    Check dated 2026-03-11T17:58:50.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The notice about government funding lapse and Revision: v3.4.1 were removed.
    Difference
    0.3%
    Check dated 2026-02-11T01:40:40.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding notice and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-03T22:24:54.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Added a glossary display and updated metadata to include Last Update Submitted that Met QC Criteria, No FEAR Act Data, and revision 3.4.0, while removing the older Last Update Submitted that met QC Criteria, No FEAR Act data, and revision 3.3.4.
    Difference
    0.2%
    Check dated 2026-01-27T17:35:50.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now displayed, replacing Revision: v3.3.3; this is a small metadata update with no impact on the study content.
    Difference
    0.0%
    Check dated 2026-01-20T14:04:28.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    New study locations were added across several regions, including Texas (USA), Brussels Capital, Flemish Brabant, Hainaut, Liège, and Namur in Belgium, Győr-Moson-Sopron and Hajdú-Bihar in Hungary, and England. Some previous location groupings were removed, and the study page revision updated from v3.3.2 to v3.3.3; the HHS Vulnerability Disclosure link was removed.
    Difference
    0.8%
    Check dated 2025-12-22T22:39:04.000Z thumbnail image

Stay in the know with updates to Tisotumab Vedotin Safety in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin Safety in Solid Tumors Clinical Trial page.